2016 ACR/ARHP Annual Meeting

November 11-16, 2016. Washington, DC.

View by Number View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 1136

Clinician Training in Motivational Communication Skills: The Impact of the Language of Change Program Among Rheumatologists from Across Canada
Abstract Number: 1227

Clinician-Led Development of a Standardised Term Set for Rheumatic and Musculoskeletal Disorders Allows Easy Creation of Large-Scale ICD-10 and Snomed CT Mapped Datasets from Routinely Collected Clinical Data
Abstract Number: 257

CNS Manifestations of Patients with Muckle-Wells Syndrome
Abstract Number: 1751

Coagulation Pathway Function in Ischemia/Reperfusion Tissue Injury in Autoimmune Prone Mice
Abstract Number: 234

Coexistent Gout and Rheumatoid Arthritis: Comparison of Comorbidity, Autoantibodies, Disease Measures, and All-Cause Mortality
Abstract Number: 2950

Cogan Syndrome: Treatment and Outcome from French Nationwide Retrospective Study and Literature Review of 62 Patients
Abstract Number: 1396

Cognitive Function in Children with SLE Nephritis: A Cross-Sectional Comparison to Children with Other Glomerular Chronic Kidney Diseases
Abstract Number: 2205

Cognitive Functioning in Fibromyalgia: The Central Role of Effort
Abstract Number: 2454

Cohort of Pregnant Women with Ro/La Antibodies: Risk of Fetal Third Degree Atrioventricular Block and Use of Hydroxychloroquine
Abstract Number: 216

Colchicine Prescribing As a Parameter for QA/QI Process in Gout Care
Abstract Number: 849

Collagen Formation/Degradation Neoepitopes Are Promising Biomarkers for Systemic Sclerosis
Abstract Number: 1455

Collagen-Induced Arthritis and Uveitis in Mice Lacking TNF Receptors
Abstract Number: 1454

Combination of the SYK Inhibitor, GS-9876, with a JAK Inhibitor Increases Efficacy in a Chronic Rat Model of Collagen-Induced Arthritis
Abstract Number: 1725

Combination Therapy of Apremilast and Biologic Agent As a Safe Option of Psoriatic Arthritis and Psoriasis
Abstract Number: 1278

Combined Positron Emission Tomography and Magnetic Resonance Imaging in Assessing Gastrointestinal Involvement in Systemic Sclerosis: A Pilot Study

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].